Estrovera - 30 tabs | Metagenics
Menopausal Hot Flash Relief
Estrovera is an extensively researched, natural approach for hot flash relief. It contains an exclusive phytoestrogenic extract of rhapontic (Siberian) rhubarb root known as ERr 731® that has been suggested to be comparable in effectiveness to an ultra low dose of conventional hormone therapies . This extract has also demonstrated significant reductions in other common menopausal symptoms and is effective in just 4 mg daily—with noticeable results in just 4 weeks.*
Like any successful approach to managing menopausal symptoms, Estrovera is recommended in conjunction with simple lifestyle modifications and healthy habits for optimal outcomes.* Women can tailor these suggestions according to their unique menopausal experience. Following are some materials to help you offer comprehensive recommendations for your menopausal patients
- Clinically shown to dramatically reduce the number of daily menopausal hot flashes.*
- Clinically demonstrated to relieve a wide range of other menopausal symptoms including:*
- Sleep disturbances
- Depressive mood, irritability, and anxiety
- Physical and emotional exhaustion
- Joint and muscle complaints
- Urinary tract symptoms
- Vaginal dryness
- Excellent safety profile supported by 2 years of clinical testing in perimenopausal women.*
- Clinically effective dose in just 1 tablet daily
Estrovera tablets by Metagenics offer a natural treatment to reduce menopausal hot flashes in just one daily dose. This product has been tested and has proven in clinical studies that it is more effective at reducing such symptoms than a placebo. In fact, the results were similar to the results of other hormone therapies.
Other symptoms that can be treated with Estrovera include:
- Irritability, anxiety and bad moods
- Trouble sleeping
- Heart complaints, such as racing, associated with menopause
- Emotional and physical fatigue
- Muscle and joint problems
- Symptoms that affect the urinary tract
- Lack of sexual desire
- Vaginal dryness
This product has been tested for use during periods of up to 2 years without any notable chances in safety parameters or serious side effects.
Hormone therapies for reducing hot flashes and other symptoms of menopause have been shown to be effective, but they also carry the risk of serious side effects. Thatís why Metagenics introduced Estrovera: an intensely-researched, completely natural and safe approach to relieving the symptoms of menopause.
Benefits to a Natural Treatment for Menopausal Symptoms
In the U.S. and other Western countries, about 80-percent of women who go through menopause suffer from hot flashes that can affect all aspects of their life. Many women opt for hormone replacement therapy for relief, simply due to their desperation for their quality of life to improve. However, hormone therapy is not a suitable long-term approach. The symptoms of menopause can be felt for years, but the side-effects of hormone therapy make it dangerous to take for such an extended period of time. This is why so many women are now turning to Estrovera for its natural approach to treating the symptoms of menopause.
Active Ingredient in Estrovera
The active ingredient in Estrovera, ERr 731 is a special extract of rhubarb root and it is only available from Metagenics. This extract, ERr 731, has been prescribed by doctors in Germany to treat menopausal hot flashes and related menopausal symptoms for years. Finally, it is now available to us in the United States, thanks to Metagenics.
ERr 731 Testing
ERr 731 has shown in various clinical studies to significantly reduce the number and intensity of a womanís hot flashes. It has also been shown to reduce a wide range of other symptoms related to menopause, including sleep troubles, poor mood, anxiety and irritability, heart complaints, lack of sexual desire, vaginal dryness and urinary tract symptoms. Many women are now choosing the ERr, found in Estrovera, because it also is proven to have an excellent safety profile without serious adverse effects in short and long (up to 2 years) term use.
In a short-term, multicenter, randomized, placebo-controlled clinical trial of 12 weeks, menopausal women displayed a 72% decrease in menopausal-related hot flashes, which is consistent with the results of hormone replacement. The same women also saw a decrease in the total MRS (Menopause Rating Scale) score when compared to women who were taking the placebo.
These statements have not been evaluated by the Food and Drug Administration (FDA). These products are not meant to diagnose, treat or cure any disease or medical condition. Please consult your doctor before starting any exercise or nutritional supplement program or before using these or any product during pregnancy or if you have a serious medical condition.
|